NovoCure : The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival - Form 8-K

(marketscreener.com) The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival Novocure announces first patients treated with new arrays Novocure to present at the 41st Annual J.P. Morgan Healthcare Conference at...https://www.marketscreener.com/quote/stock/NOVOCURE-LIMITED-24157014/news/NovoCure-The-LUNAR-study-met-its-primary-endpoint-demonstrating-a-statistically-significant-and-c-42691563/?utm_medium=RSS&utm_content=20230109